FAIM2, as a novel diagnostic maker and a potential therapeutic target for small-cell lung cancer and atypical carcinoid. - Wikidata - wikimedia - TriplyDB

FAIM2, as a novel diagnostic maker and a potential therapeutic target for small-cell lung cancer and atypical carcinoid.

FAIM2, as a novel diagnostic maker and a potential therapeutic target for small-cell lung cancer and atypical carcinoid.

http://www.wikidata.org/entity/Q37291399

about

miR-193b availability is antagonized by LncRNA-SNHG7 for FAIM2-induced tumour progression in non-small cell lung cancer.

P2860

Q47713726-616C29E2-F790-40E9-B5F5-A47F18901D59

P2860

FAIM2, as a novel diagnostic maker and a potential therapeutic target for small-cell lung cancer and atypical carcinoid.

http://www.wikidata.org/entity/Q37291399

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

FAIM2, as a novel diagnostic m ...... cancer and atypical carcinoid.

@en

FAIM2, as a novel diagnostic m ...... cancer and atypical carcinoid.

@nl

type

label

FAIM2, as a novel diagnostic m ...... cancer and atypical carcinoid.

@en

FAIM2, as a novel diagnostic m ...... cancer and atypical carcinoid.

@nl

prefLabel

FAIM2, as a novel diagnostic m ...... cancer and atypical carcinoid.

@en

FAIM2, as a novel diagnostic m ...... cancer and atypical carcinoid.

@nl

P1433

Q37291399-77DE3425-5D13-4922-A2D6-80CB18D1DC79

P1476

Q37291399-06802E23-A310-4691-BF2B-00F1F1E31EE9

P2093

Q37291399-0209AC4C-C0DE-4382-95BA-1CE693B8F6AC

Q37291399-06DBC1C4-B32B-4BEC-9B61-6C27CEE011E5

Q37291399-0B3AB3D7-9EE1-405E-8BB4-616DDE4AE20D

Q37291399-2CB2726E-A1F9-4033-9E60-F7EFDEEBF633

Q37291399-BA085D95-C189-4D9C-92FA-DCDF946DA2B8

Q37291399-E18593D9-07B7-4648-874E-308C56DF0EF2

Q37291399-ED7F1D9F-33E3-4D7C-AECC-FF206B975B1A

Q37291399-EF92D5BC-27ED-41AC-8186-070341C2962E

P2860

Q37291399-19732E33-7518-4ACA-AB7F-620C9089C8E6

Q37291399-313F457C-16BA-4EB8-98A3-3BE7342DD6E3

Q37291399-34077C8E-90B5-4029-A683-DEB81D24B7F0

Q37291399-43024755-2B90-4E15-90AB-94CCC288936B

Q37291399-4CDC1F57-326D-4E62-A6E1-81AA9311BEA3

Q37291399-4E5E1743-1BDE-433A-B785-7BD1C1BB190F

Q37291399-6E67A1A7-E712-4A5B-95F2-3F75B78214EE

Q37291399-74B36BD2-C98C-434E-BF7F-FB03A9DD8270

Q37291399-78B0B524-AB90-4480-BB1A-CC6FAE7A07C2

Q37291399-909BA36A-5A0A-428D-AF1B-A8CECC237DD3

P2888

Q37291399-5E203B04-273F-4C2D-87CE-44A623B51431

P304

Q37291399-AD243161-FBCE-4FB6-BF6C-383CD5AFE686

P31

Q37291399-435F098B-5AF4-4A92-BB6F-C5CB45A91B64

P356

Q37291399-617ACFA5-1FAC-44FC-B05C-8C0EAC8DEEAB

P407

Q37291399-5F7C1A54-76A1-445A-8F79-A995D9A8A6DC

P478

Q37291399-A8B50278-C4EB-43D5-B982-7FFA010ADA4F

P577

Q37291399-4ECA02AF-DEB9-41E5-846B-1281362D88B1

P698

Q37291399-452FD51A-A4D7-47A8-AA0D-48D86EF35CF3

P921

Q37291399-10a3a464-179f-4577-b5fd-a57795ab503b

P932

Q37291399-712863AA-6920-4C7B-8439-FD19B03502D0

P356

P1433

Scientific Reports

P1476

FAIM2, as a novel diagnostic m ...... cancer and atypical carcinoid.

@en

P2093

David M Jablons

http://www.w3.org/2001/XMLSchema#string

Gavitt Woodard

http://www.w3.org/2001/XMLSchema#string

Hee Kyung Chang

http://www.w3.org/2001/XMLSchema#string

Hio Chung Kang

http://www.w3.org/2001/XMLSchema#string

Il-Jin Kim

http://www.w3.org/2001/XMLSchema#string

Ja-Lok Ku

http://www.w3.org/2001/XMLSchema#string

Jong In Kim

http://www.w3.org/2001/XMLSchema#string

Young Sik Choi

http://www.w3.org/2001/XMLSchema#string

P2860

LFG: an anti-apoptotic gene that provides protection from Fas-mediated cell death

A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro

Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Antiapoptotic protein Lifeguard is required for survival and maintenance of Purkinje and granular cells

Small cell lung cancer: where do we go from here?

Relapsed small cell lung cancer: treatment options and latest developments.

P2888

P304

34022

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP34022

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27677402

http://www.w3.org/2001/XMLSchema#string

P921

P932

5039724

http://www.w3.org/2001/XMLSchema#string